These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 23281408)

  • 1. Signaling effectors underlying pathologic growth and remodeling of the heart.
    van Berlo JH; Maillet M; Molkentin JD
    J Clin Invest; 2013 Jan; 123(1):37-45. PubMed ID: 23281408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cardiac hypertrophy: toward a causal heart failure therapy.
    Bisping E; Wakula P; Poteser M; Heinzel FR
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):293-305. PubMed ID: 25286359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic heart failure (VI). Ventricular arrhythmias in heart failure].
    Arribas F; García Cosío F
    Rev Esp Cardiol; 1992 Feb; 45(2):128-40. PubMed ID: 1532863
    [No Abstract]   [Full Text] [Related]  

  • 5. Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias.
    Glück T; Alter P
    Vascul Pharmacol; 2016 Jul; 82():11-9. PubMed ID: 27080538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.
    Li H; Wang Y; Liu J; Chen X; Duan Y; Wang X; Shen Y; Kuang Y; Zhuang T; Tomlinson B; Chan P; Yu Z; Cheng Y; Zhang L; Liu Z; Zhang Y; Zhao Z; Zhang Q; Liu J
    Theranostics; 2021; 11(4):1609-1625. PubMed ID: 33408770
    [No Abstract]   [Full Text] [Related]  

  • 7. An "I" on cardiac hypertrophic remodelling: imidazoline receptors and heart disease.
    Mukaddam-Daher S
    Can J Cardiol; 2012; 28(5):590-8. PubMed ID: 22483786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial morphological characteristics and proarrhythmic substrate in the rat model of heart failure due to chronic volume overload.
    Benes J; Melenovsky V; Skaroupkova P; Pospisilova J; Petrak J; Cervenka L; Sedmera D
    Anat Rec (Hoboken); 2011 Jan; 294(1):102-11. PubMed ID: 21157921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less heart is more.
    Zipes DP
    Circulation; 2003 May; 107(20):2531-2. PubMed ID: 12777316
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
    Martinez FA
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-1231 regulates L-calcium in ventricular arrhythmia in chronic heart failure.
    Shi Y; Qiao L; Han F; Xie X; Wang W
    Minerva Med; 2021 Apr; 112(2):305-306. PubMed ID: 31317688
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNAs in Cardiac Hypertrophy.
    Wehbe N; Nasser SA; Pintus G; Badran A; Eid AH; Baydoun E
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.
    Haque ZK; Wang DZ
    Cell Mol Life Sci; 2017 Mar; 74(6):983-1000. PubMed ID: 27714411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological remodeling in hypertrophy and heart failure.
    Tomaselli GF; Marbán E
    Cardiovasc Res; 1999 May; 42(2):270-83. PubMed ID: 10533566
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt Signaling in Cardiac Remodeling and Heart Failure.
    Stylianidis V; Hermans KCM; Blankesteijn WM
    Handb Exp Pharmacol; 2017; 243():371-393. PubMed ID: 27838851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.